
Savitha M. Rao
Examiner (ID: 10492, Phone: (571)270-5315 , Office: P/1621 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629, 1614, 1621, 1691, 4131 |
| Total Applications | 1525 |
| Issued Applications | 872 |
| Pending Applications | 108 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9657387
[patent_doc_number] => 20140228391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'Anise Flavored Medication'
[patent_app_type] => utility
[patent_app_number] => 14/179606
[patent_app_country] => US
[patent_app_date] => 2014-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7944
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14179606
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/179606 | Anise flavored medication | Feb 12, 2014 | Issued |
| 13/999331 | Compositions and methods of use of phorbol esters for treatment of stroke | Feb 12, 2014 | Abandoned |
Array
(
[id] => 10912901
[patent_doc_number] => 20140315920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'TREATMENT AND PROGNOSTIC MONITORING OF PROLIFERATION DISORDERS USING HEDGEHOG PATHWAY INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/173588
[patent_app_country] => US
[patent_app_date] => 2014-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 27340
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14173588
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/173588 | Treatment and prognostic monitoring of proliferation disorders using hedgehog pathway inhibitors | Feb 4, 2014 | Issued |
Array
(
[id] => 9811999
[patent_doc_number] => 20150023940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-22
[patent_title] => 'METHODS FOR TREATMENT OF ONCOLOGICAL DISORDERS USING AN EPIMETABOLIC SHIFTER (COENZYME Q10)'
[patent_app_type] => utility
[patent_app_number] => 14/171419
[patent_app_country] => US
[patent_app_date] => 2014-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 86998
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14171419
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/171419 | Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10) | Feb 2, 2014 | Issued |
Array
(
[id] => 9490694
[patent_doc_number] => 20140141099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'DRUG DISCOVERY METHODS'
[patent_app_type] => utility
[patent_app_number] => 13/930052
[patent_app_country] => US
[patent_app_date] => 2014-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 17991
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13930052
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/930052 | DRUG DISCOVERY METHODS | Jan 26, 2014 | Abandoned |
Array
(
[id] => 9436020
[patent_doc_number] => 20140113927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-24
[patent_title] => 'TREATMENT UTILIZING HYDROPHOBIC WEAK BASES CHEMOTHERAPEUTIC AGENTS AND ILLUMINATION'
[patent_app_type] => utility
[patent_app_number] => 14/146064
[patent_app_country] => US
[patent_app_date] => 2014-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 22575
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14146064
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/146064 | Treatment utilizing hydrophobic weak bases chemotherapeutic agents and illumination | Jan 1, 2014 | Issued |
Array
(
[id] => 9569919
[patent_doc_number] => 20140187632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'LIPID COMPOSITIONS FOR THE TREATMENT OF GASTRO-INTESTINAL DISORDERS AND THE PROMOTION OF INTESTINAL DEVELOPMENT AND MATURATION'
[patent_app_type] => utility
[patent_app_number] => 14/136373
[patent_app_country] => US
[patent_app_date] => 2013-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13893
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14136373
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/136373 | Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation | Dec 19, 2013 | Issued |
Array
(
[id] => 10997329
[patent_doc_number] => 20160194274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'PHENANTHRENE DERIVATIVES FOR USE AS MEDICAMENTS'
[patent_app_type] => utility
[patent_app_number] => 14/735772
[patent_app_country] => US
[patent_app_date] => 2013-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 8332
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14735772
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/735772 | PHENANTHRENE DERIVATIVES FOR USE AS MEDICAMENTS | Dec 12, 2013 | Abandoned |
Array
(
[id] => 10831591
[patent_doc_number] => 08859760
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-14
[patent_title] => 'Compositions for killing or preventing the growth of microbes'
[patent_app_type] => utility
[patent_app_number] => 14/104098
[patent_app_country] => US
[patent_app_date] => 2013-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5427
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14104098
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/104098 | Compositions for killing or preventing the growth of microbes | Dec 11, 2013 | Issued |
Array
(
[id] => 9384707
[patent_doc_number] => 20140088189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'METHODS FOR REDUCING THE RISK OF AN ADVERSE DRONEDARONE / BETA-BLOCKERS INTERACTION IN A PATIENT SUFFERING FROM ATRIAL FIBRILATION'
[patent_app_type] => utility
[patent_app_number] => 14/087786
[patent_app_country] => US
[patent_app_date] => 2013-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5442
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14087786
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/087786 | METHODS FOR REDUCING THE RISK OF AN ADVERSE DRONEDARONE / BETA-BLOCKERS INTERACTION IN A PATIENT SUFFERING FROM ATRIAL FIBRILATION | Nov 21, 2013 | Abandoned |
Array
(
[id] => 9589440
[patent_doc_number] => 08778981
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-15
[patent_title] => 'Methods and compositions for locally increasing body fat'
[patent_app_type] => utility
[patent_app_number] => 14/086785
[patent_app_country] => US
[patent_app_date] => 2013-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 29220
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14086785
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/086785 | Methods and compositions for locally increasing body fat | Nov 20, 2013 | Issued |
Array
(
[id] => 9875354
[patent_doc_number] => 08962620
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-24
[patent_title] => 'Substituted 6,5-fused bicyclic heteroaryl compounds'
[patent_app_type] => utility
[patent_app_number] => 14/070675
[patent_app_country] => US
[patent_app_date] => 2013-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 100776
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14070675
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/070675 | Substituted 6,5-fused bicyclic heteroaryl compounds | Nov 3, 2013 | Issued |
Array
(
[id] => 10049629
[patent_doc_number] => 09089483
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-28
[patent_title] => 'Self-emulsifying composition of OMEGA3 fatty acid'
[patent_app_type] => utility
[patent_app_number] => 14/069718
[patent_app_country] => US
[patent_app_date] => 2013-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13807
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14069718
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/069718 | Self-emulsifying composition of OMEGA3 fatty acid | Oct 31, 2013 | Issued |
Array
(
[id] => 11427940
[patent_doc_number] => 09566243
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-14
[patent_title] => 'Apparatus and method for cryogranulating a pharmaceutical composition'
[patent_app_type] => utility
[patent_app_number] => 14/065609
[patent_app_country] => US
[patent_app_date] => 2013-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5270
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14065609
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/065609 | Apparatus and method for cryogranulating a pharmaceutical composition | Oct 28, 2013 | Issued |
Array
(
[id] => 9827871
[patent_doc_number] => 08937100
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-20
[patent_title] => 'Cosmetic composition containing calcium citrate and N-acylated aminoalcohol derivative'
[patent_app_type] => utility
[patent_app_number] => 14/059761
[patent_app_country] => US
[patent_app_date] => 2013-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11361
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14059761
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/059761 | Cosmetic composition containing calcium citrate and N-acylated aminoalcohol derivative | Oct 21, 2013 | Issued |
Array
(
[id] => 9686593
[patent_doc_number] => 20140243358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'METHOD OF PREVENTING AND TREATING HEPATIC DISEASE USING A2B ADENOSINE RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 14/046847
[patent_app_country] => US
[patent_app_date] => 2013-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 21951
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14046847
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/046847 | METHOD OF PREVENTING AND TREATING HEPATIC DISEASE USING A2B ADENOSINE RECEPTOR ANTAGONISTS | Oct 3, 2013 | Abandoned |
Array
(
[id] => 9384565
[patent_doc_number] => 20140088047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'USE OF LONG CHAIN POLYUNSATURATED FATTY ACID DERIVATIVES TO TREAT SICKLE CELL DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/035206
[patent_app_country] => US
[patent_app_date] => 2013-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8207
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14035206
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/035206 | USE OF LONG CHAIN POLYUNSATURATED FATTY ACID DERIVATIVES TO TREAT SICKLE CELL DISEASE | Sep 23, 2013 | Abandoned |
Array
(
[id] => 9370994
[patent_doc_number] => 20140080868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-20
[patent_title] => 'Methods for Treating HCV'
[patent_app_type] => utility
[patent_app_number] => 14/029302
[patent_app_country] => US
[patent_app_date] => 2013-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10398
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14029302
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/029302 | Methods for Treating HCV | Sep 16, 2013 | Abandoned |
Array
(
[id] => 11581697
[patent_doc_number] => 09636317
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-02
[patent_title] => 'Compositions and methods of use of phorbol esters'
[patent_app_type] => utility
[patent_app_number] => 14/027320
[patent_app_country] => US
[patent_app_date] => 2013-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42904
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14027320
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/027320 | Compositions and methods of use of phorbol esters | Sep 15, 2013 | Issued |
Array
(
[id] => 11357296
[patent_doc_number] => 09533938
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-03
[patent_title] => 'Compositions and methods of use of phorbol esters for the treatment of stroke'
[patent_app_type] => utility
[patent_app_number] => 14/026534
[patent_app_country] => US
[patent_app_date] => 2013-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14398
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14026534
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/026534 | Compositions and methods of use of phorbol esters for the treatment of stroke | Sep 12, 2013 | Issued |